Most popular ovarian cancer cell lines do not resemble ovarian cancer

July 15, 2013, Memorial Sloan-Kettering Cancer Center

(Medical Xpress)—Researchers from Memorial Sloan-Kettering Cancer Center recently discovered that the most frequently used cancer cell lines in ovarian cancer research are not suitable models of ovarian cancer. Their findings are the result of a detailed review of genomic data that recently became publicly available. Their methods, published in this week's Nature Communications, could provide a usable framework for other researchers to better assess cell lines' validity for future use in this and in other types of cancer research.

Computational biologists Nikolaus Schultz and Rileen Sinha, and biochemist Silvia Domcke, focused their review on high-grade serous ovarian cancer (HGSOC), the most commonly diagnosed and frequently studied subtype of ovarian cancer. Using datasets from The Cancer Genome Atlas and the Cancer Cell Line Encyclopedia, which detail and define the genomic features of numerous clinical samples and cell lines, the team analyzed and then ranked several cell lines by their genomic similarities to tissue samples and, in doing so, uncovered multiple discrepencies between the cell lines and actual human tumors.

"Our review showed that the two most utilized cell lines, accounting for almost 60 percent of all published research studies, do not resemble HGSOC well at all," explained Dr. Schultz, the paper's lead author. "The problem with this is, investigators assumed they were studying high-grade serous , when in reality they were looking at something else. So conclusions drawn from this work might be misleading."

Cancer cell lines are generated and grown indefinitely in laboratories around the world, but are ultimately derived from human tumors. For the past several decades, they have been the most popular model for the study of cancer because they are inexpensive and easy to replicate. However, the origin of some cell lines is not well established, and through years in culture, they can acquire additional changes, making them less desirable.

"With the explosion of now at our fingertips and the potential for more to become available, it's our hope that this approach can be used by our colleagues to choose optimal cell lines, as we do expect similar discrepencies in other tumor types," said Dr. Schultz. "Overall, we believe these findings should greatly benefit the study of cancer."

Explore further: Resistance is futile: Researchers identify gene that mediates cisplatin resistance in ovarian cancer

Related Stories

Resistance is futile: Researchers identify gene that mediates cisplatin resistance in ovarian cancer

April 15, 2013
Platinum compounds, such as cisplatin and carboplatin, induce DNA cross-linking, prohibiting DNA synthesis and repair in rapidly dividing cells. They are first line therapeutics in the treatment of many solid tumors, but ...

Tools for better understanding breast cancer stem cells

June 4, 2013
A joint project between the Griffith University and the UQ Centre for clinical Research (UQCCR) has characterised an in vitro model that allows further studies on the breast cancer biology.

Mechanisms of acquired chemoresistance in ovarian cancer identified

August 15, 2012
The presence of multiple ovarian cancer genomes in an individual patient and the absence or downregulation of the gene LRP1B are associated with the development of chemoresistance in women with the high-grade serous cancer ...

Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs, PARP inhibitors

April 3, 2013
Poly (ADP-ribose) polymerase inhibitors may be a novel treatment strategy for patients with cancer that has become resistant to the commonly used chemotherapy drug cisplatin, according to data from a preclinical study published ...

New study highlights strong anti-cancer properties of soybeans

March 20, 2013
Soybean meal is a bi-product following oil extraction from soybean seeds. It is rich in protein, which usually makes up around 40% of the nutritional components of the seeds and dependent on the line, and can also contain ...

Scientists create method to personalize chemotherapy drug selection

February 14, 2013
In laboratory studies, scientists at the Johns Hopkins Kimmel Cancer Center have developed a way to personalize chemotherapy drug selection for cancer patients by using cell lines created from their own tumors.

Recommended for you

Study suggests well-known growth suppressor actually fuels lethal brain cancers

June 18, 2018
Scientists report finding a potentially promising treatment target for aggressive and deadly high-grade brain cancers like glioblastoma. But they also say the current lack of a drug that hits the molecular target keeps it ...

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

Researchers create novel combination as potential therapy for high-risk neuroblastoma

June 18, 2018
Researchers at VCU Massey Cancer Center in Richmond, Virginia, have identified a promising target to reverse the development of high-risk neuroblastoma and potentially inform the creation of novel combination therapies for ...

Genomics offers new treatment options for infants with range of soft tissue tumors

June 18, 2018
The genetic causes of a group of related infant cancers have been discovered by scientists at the Wellcome Sanger Institute, the University of Wuerzburg and their collaborators. Whole genome sequencing of tumours revealed ...

Standard myelofibrosis drug can awaken 'dormant' lymphoma

June 18, 2018
Most patients with myelofibrosis, a rare chronic disorder of the haematopoietic cells of the bone marrow, benefit from drugs from the JAK2 inhibitor class: symptoms are relieved, survival extended and general quality-of-life ...

Breast cancer researcher warns against online genetic tests

June 18, 2018
We have never been so fascinated by the secrets inside our cells.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.